Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Poluzzi

Showing results (61-70 of 189) with videos related to

Pageof 19
Sort By:
Journal of Clinical Psychopharmacology|June 20, 2024
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports: A Note of CautionMichele Fusaroli, Charles Khouri, Elisabetta Poluzzi, et al.
Plos One|October 16, 2020
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptionsMarica Iommi, Simona Rosa, Michele Fusaroli, et al.
Journal of Affective Disorders|January 6, 2026
Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribersEmanuel Raschi, Margherita Nannini, François Montastruc, et al.
Current Medicinal Chemistry|October 30, 2013
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspectiveElisabetta Poluzzi, Carlo Piccinni, Emanuel Raschi, et al.
Expert Opinion on Pharmacotherapy|January 20, 2022
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fractionEmanuel Raschi, Igor Diemberger, Mario Sabatino, et al.
Targeted Oncology|July 30, 2020
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from PharmacovigilanceEmanuel Raschi, Milo Gatti, Francesco Gelsomino, et al.
British Journal of Clinical Pharmacology|March 23, 2024
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forwardElisabetta Poluzzi, Emanuel Raschi, Carlotta Lunghi, et al.
Current Treatment Options in Gastroenterology|March 17, 2005
Idiopathic DyspepsiaVincenzo Stanghellini, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Drug Safety|March 2, 2012
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system databaseDomenico Motola, Carlo Piccinni, Chiara Biagi, et al.
Current Heart Failure Reports|October 7, 2020
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and ProarrhythmiaMilo Gatti, Emanuel Raschi, Elisabetta Poluzzi, et al.
Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Psychopharmacology|June 20, 2024
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports: A Note of CautionMichele Fusaroli, Charles Khouri, Elisabetta Poluzzi, et al.
Plos One|October 16, 2020
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptionsMarica Iommi, Simona Rosa, Michele Fusaroli, et al.
Journal of Affective Disorders|January 6, 2026
Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribersEmanuel Raschi, Margherita Nannini, François Montastruc, et al.
Current Medicinal Chemistry|October 30, 2013
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspectiveElisabetta Poluzzi, Carlo Piccinni, Emanuel Raschi, et al.
Expert Opinion on Pharmacotherapy|January 20, 2022
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fractionEmanuel Raschi, Igor Diemberger, Mario Sabatino, et al.
Targeted Oncology|July 30, 2020
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from PharmacovigilanceEmanuel Raschi, Milo Gatti, Francesco Gelsomino, et al.
British Journal of Clinical Pharmacology|March 23, 2024
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forwardElisabetta Poluzzi, Emanuel Raschi, Carlotta Lunghi, et al.
Current Treatment Options in Gastroenterology|March 17, 2005
Idiopathic DyspepsiaVincenzo Stanghellini, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Drug Safety|March 2, 2012
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system databaseDomenico Motola, Carlo Piccinni, Chiara Biagi, et al.
Current Heart Failure Reports|October 7, 2020
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and ProarrhythmiaMilo Gatti, Emanuel Raschi, Elisabetta Poluzzi, et al.
Pageof 19